RMEBX | RSOOX | RMEBX / RSOOX | |
Total Expense Ratio | 1.07 | 1.32 | 81% |
Annual Report Gross Expense Ratio | 1.07 | 1.32 | 81% |
Fund Existence | 11 years | 17 years | - |
Gain YTD | 10.612 | 7.809 | 136% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 110B | 2.14B | 5,140% |
Annual Yield % from dividends | 1.11 | 2.35 | 47% |
Returns for 1 year | 7.63 | 5.96 | 128% |
Returns for 3 years | 22.19 | 14.25 | 156% |
Returns for 5 years | 53.85 | 39.10 | 138% |
Returns for 10 years | 77.43 | 32.54 | 238% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PHPSX | 21.80 | 0.16 | +0.74% |
ProFunds Pharmaceuticals UltraSector Svc | |||
AEDYX | 35.98 | 0.09 | +0.25% |
Invesco EQV European Equity Y | |||
FCSDX | 17.59 | N/A | N/A |
Fidelity Advisor Strategic Div & Inc C | |||
ASQGX | 17.07 | -0.05 | -0.29% |
American Century Small Company R5 | |||
FISVX | 25.90 | -0.19 | -0.73% |
Fidelity Small Cap Value Index |